We Need to Talk About Corruption in Health Systems

Document Type : Editorial

Authors

1 Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK

2 Department of Public Health & Policy, London School of Hygiene and Tropical Medicine, London, UK

Abstract

The health sector consistently appears prominently in surveys of perceived corruption, with considerable evidence that this has serious adverse consequences for patients. Yet this issue is far from prominent in the international health policy discourse. We identify five reasons why the health policy community has been reluctant to talk about it. These are the problem of defining corruption, the fact that some corrupt practices are actually ways of making dysfunctional systems work, the serious challenges to researching corruption, concerns that a focus on corruption is a form of victim blaming that ignores larger issues, and a lack of evidence about what works to tackle it. We propose three things that can be done to address this situation. First, seek consensus on the scale and nature of corruption. Second, decide on priorities, taking account the importance of the particular problem and the feasibility of doing something about it. Third, take a holistic view, drawing on a wide range of disciplines.

Highlights

 

Commentaries Published on this Paper

 

  • High Stakes Require More Than Just Talk: What to Do About Corruption in Health Systems; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • Some Things Are Rarely Discussed in Public – on the Discourse of Corruption in Healthcare; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • All It Takes for Corruption in Health Systems to Triumph, Is Good People Who Do Nothing; Comment on “We Need to Talk About Corruption in Health Systems”

         Abstract | PDF

 

  • I Know It When I See It: The Challenges of Addressing Corruption in Health Systems; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • It Will Take a Global Movement to Curb Corruption in Health Systems; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • Demystify False Dilemmas to Speak About Corruption in Health Systems: Different Actors, Different Perspectives, Different Strategies; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • We Need to Measure and Address Corruption and Poor Governance in Health Systems; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • Opening the Policy Window to Mobilize Action Against Corruption in the Health Sector; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • Corruption – Taking a Deeper Dive; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • Not Up for Discussion: Applying Lukes’ Power Model to the Study of Health System Corruption; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • Our Blind Spots in the Fight Against Health Systems Corruption; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • Corruption in Health Systems: The Conversation Has Started, Now Time to Continue it; Comment on “We Need to Talk About Corruption in Health Systems”

           Abstract | PDF

 

  • Why We Must Talk About Institutional Corruption to Understand Wrongdoing in the Health Sector; Comment on “We Need to Talk About Corruption in Health Systems”

          Abstract | PDF

 

  • Changing the Conversation, Why We Need to Reframe Corruption as a Public Health Issue; Comment on “We Need to Talk About Corruption in Health Systems”

         Abstract | PDF

 

Authors' Response to the Commentaries

 

  • Beyond Talking: We Need Effective Measures to Tackle Systemic Corruption and the Power That Allows It to Persist in Health Systems; A Response to Recent Commentaries

          Abstract | PDF

 

Watch the Video Summary here.

 

Keywords

Main Subjects

Full Text

 

 

References

  1. Jagsi R. Sexual Harassment in Medicine - #MeToo. N Engl J Med. 2018;378(3):209-211. doi:10.1056/NEJMp1715962
  2. Jain A, Nundy S, Abbasi K. Corruption: medicine’s dirty open secret. BMJ. 2014;348:g4184. doi:10.1136/bmj.g4184
  3. Transparency International‎. Global corruption barometer 2013 report. 2013; https://www.transparency.org/gcb2013. Accessed October 31, 2018.
  4. Vian T. Review of corruption in the health sector: theory, methods and interventions. Health policy planning. 2008;23(2):83-94.
  5. Petkov M, Cohen D. Diagnosing corruption in health care. 2016; https://www.transparency.org.uk/wp-content/plugins/download-attachments/includes/download.php?id=5804. Accessed October 31, 2018.
  6. Berger D. Corruption ruins the doctor-patient relationship in India. BMJ. 2014;348:g3169.
  7. Hanf M, Van-Melle A, Fraisse F, Roger A, Carme B, Nacher M. Corruption kills: estimating the global impact of corruption on children deaths. PLoS One. 2011;6(11):e26990. doi:10.1371/journal.pone.0026990
  8. Mackey TK, Vian T, Kohler J. The sustainable development goals as a framework to combat health-sector corruption. Bull World Health Organ. 2018;96(9):634-643. doi:10.2471/blt.18.209502
  9. United Nations. Convention against Corruption. New York: United Nations; 2003.
  10. Gaitonde R, Oxman AD, Okebukola PO, Rada G. Interventions to reduce corruption in the health sector. Cochrane Database Syst Rev. 2016(8):Cd008856. doi:10.1002/14651858.CD008856.pub2
  11. Vian T, Nordberg C. Corruption and the health sector. Bergen: Anti-Corruption Resource Centre, CHR Michelsen Institute; 2002.
  12. Fadlallah R, Alkhaled L, Brax H, et al. Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review. Eur J Public Health. 2018;28(2):224-230. doi:10.1093/eurpub/ckx204
  13. Fickweiler F, Fickweiler W, Urbach E. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review. BMJ Open. 2017;7(9):e016408. doi:10.1136/bmjopen-2017-016408
  14. Balabanova D, McKee M. Understanding informal payments for health care: the example of Bulgaria. Health Policy. 2002;62(3):243-273.
  15. Gaal P, Belli PC, McKee M, Szocska M. Informal payments for health care: definitions, distinctions, and dilemmas. J Health Polit Policy Law. 2006;31(2):251-293. doi:10.1215/03616878-31-2-251
  16. Lewis M. Informal payments and the financing of health care in developing and transition countries. Health Aff (Millwood). 2007;26(4):984-997. doi:10.1377/hlthaff.26.4.984
  17. Lindelow M, Serneels P. The performance of health workers in Ethiopia: results from qualitative research. Soc Sci Med. 2006;62(9):2225-2235. doi:10.1016/j.socscimed.2005.10.015
  18. Garcia-Prado A, Chawla M. The impact of hospital management reforms on absenteeism in Costa Rica. Health Policy Plan. 2006;21(2):91-100. doi:10.1093/heapol/czj015
  19. Randall D, Anderson A, Taylor J. Protecting children in research: Safer ways to research with children who may be experiencing violence or abuse. J Child Health Care. 2016;20(3):344-353. doi:10.1177/1367493515587060
  20. Bedirhanoğlu P. The neoliberal discourse on corruption as a means of consent building: reflections from post-crisis Turkey. Third World Quarterly. 2007;28(7):1239-1254.
  21. Khan MH. Introduction: Political Settlements and the Analysis of Institutions. Afr Aff (Lond). 2017:1-20.
  22. Kingdon JW, Thurber JA. Agendas, alternatives, and public policies. Boston: Little, Brown 1984.
  23. Zyglidopoulos S, Hirsch P, Martin de Holan P, Phillips N. Expanding Research on Corporate Corruption, Management, and Organizations. Los Angeles, CA: SAGE Publications; 2017.
  24. Anand V, Ashforth BE, Joshi M. Business as usual: The acceptance and perpetuation of corruption in organizations. Acad Manag Perspect. 2004;18(2):39-53.
  25. Anechiarico F, Jacobs JB, Jacobs JB. The pursuit of absolute integrity: How corruption control makes government ineffective. Chicago, IL: University of Chicago Press; 1996.
  26. Wedeman A. Looters, rent-scrapers, and dividend-collectors: Corruption and growth in Zaire, South Korea, and the Philippines. J Dev Areas. 1997;31(4):457-478.
  27. Hirsch PM, Milner D. When scandals yield “it’s about time!” Rather than “We’re shocked and surprised!.” Journal of Management Inquiry. 2016;25(4):447-449.
  28. Hlatshwayo S, Oeking A, Ghazanchyan MM, Corvino D, Shukla A, Leigh MLY. The Measurement and Macro-Relevance of Corruption: A Big Data Approach. Washington DC: International Monetary Fund; 2018.
  29. Diviák T, Dijkstra JK, Snijders TA. Structure, multiplexity, and centrality in a corruption network: the Czech Rath affair. Trends Organ Crime. 2018. doi:10.1007/s12117-018-9334-y
  30. Colladon AF, Remondi E. Using social network analysis to prevent money laundering. Expert Syst Appl. 2017;67:49-58.
International Journal of Health Policy and Management
Volume 8, Issue 4
April 2019
Pages 191-194

Files

History

  • Receive Date: 02 November 2018
  • Revise Date: 07 December 2018
  • Accept Date: 09 December 2018
  • First Publish Date: 01 April 2019

Share

How to cite

Statistics